Cite

HARVARD Citation

    Kane, J. et al. (2020). 185 The Safety and Tolerability of Lumateperone 42 mg for the Treatment of Schizophrenia: A Pooled Analysis of 3 Randomized Placebo-Controlled Trials. CNS spectrums. pp. 316-317. [Online]. 
  
Back to record